Walvax is working with the Academy of Military Science (AMS) and Suzhou Abogen Biosciences to jointly develop the shot known as ARCoV or ARCoVax, China's first mRNA vaccine to enter Phase III trials.
The shot could be stored at 2-8 degrees Celsius for six months, a much less stringent temperature requirement than shots from western rivals, an AMS researcher leading the vaccine project said in April during a presentation at a vaccine event.
First thing worth to mention:
- Walvax is the producer.
- AMS is the researcher
- Abogen Bio is the one providing the technique to produce. The Lipid Nano Particle (LNP).
- Pfizer is the producer = Walvax.
- BioNTech holds patent of LNP = Abogen
- BioNTech has been researching mRNA = AMS
- Why Trump wanted to buy up BioNTech out right in early 2020.
- Why Biden "offered" to waive patent. (Because US has none, he is just screwing the Germans)